Prime is selected to the Endpoints 11 2021 list
The Cambridge company was founded by David Liu, a researcher at the Broad Institute of MIT and Harvard
The gene editing technology Crispr may have been Nobel Prize-worthy, but Andrew Anzalone was convinced he could make it even better.
Keith and his team of physician-scientists are driven by their motivation to help people with genetic diseases.
Prime is emerging with ambitions to apply the new technology across the body,
On Tuesday, the belle of the launch ball was gene editing company Prime Medicine.
After a year in the shadows, Prime Medicine is breaking cover with $315 million to develop a new kind of gene editing.
A presentation on Prime Editing by Dr. Andrew Anzalone.
Prime editors enable different types of small mutations to be introduced into genomes.
Improvements to base editing could pave the way for safer gene therapies.
He has answers.
"Prime editing" is turning heads because it steers around a few central shortcomings of its predecessor.
Jeremy S. Duffield MD PhD FRCP
Vivian W. Choi PhD
Rachael Cohen
Jessie R. Davis, Samagya Banskota, Jonathan M. Levy, Gregory A. Newby, Xiao Wang, Andrew V. Anzalone, Andrew T. Nelson, Peter J. Chen, Andrew D. Hennes, Meirui An, Heejin Roh, Peyton B. Randolph, Kiran Musunuru & David R. Liu
Andrew V. Anzalone, Xin D. Gao, Christopher J. Podracky, Andrew T. Nelson, Luke W. Koblan, Aditya Raguram, Jonathan M. Levy, Jaron A.M. Mercer & David R. Liu
Peter J. Chen, Jeffrey A. Hussmann, Jun Yan, Friederike Knipping, Purnima Ravisankar, Pin-Fang Chen, Cidi Chen, James W. Nelson, Gregory A. Newby, Mustafa Sahin, Mark J. Osborn, Jonathan S. Weissman, Britt Adamson & David R. Liu
James W. Nelson, Peyton B. Randolph, Simon P. Shen, Kelcee A. Everette, Peter J. Chen, Andrew V. Anzalone, Meirui An, Gregory A. Newby, Jonathan C. Chen, Alvin Hsu & David R. Liu
Andrew V. Anzalone, Luke W. Koblan & David R. Liu
Fyodor D. Urnov, Ph.D.
Andrew V. Anzalone, Peyton B. Randolph, Jessie R. Davis, Alexander A. Sousa, Luke W. Koblan, Jonathan M. Levy, Peter J. Chen, Christopher Wilson, Gregory A. Newby, Aditya Raguram & David R. Liu